Jeff Cohen
Stock Analyst at Ladenburg Thalmann
(2.27)
# 659
Out of 5,319 analysts
24
Total ratings
69.23%
Success rate
30.12%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CBLL CeriBell | Initiates Coverage On: Buy | 32 | 14.85 | 115.49% | 1 | Apr 4, 2025 | |
BBNX Beta Bionics | Initiates Coverage On: Buy | 31 | 11.14 | 178.28% | 1 | Feb 20, 2025 | |
LGCY Legacy Education | Maintains: Strong Buy | 10 11 | 6.45 | 67.44% | 2 | Feb 14, 2025 | |
BNGO Bionano Genomics | Downgrades: Neutral | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
SNOA Sonoma Pharmaceutica... | Initiates Coverage On: Buy | 65 | 2.3 | 2726.09% | 1 | Sep 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | n/a | n/a | 1 | Jan 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 52 | 33.61 | 54.72% | 1 | Jul 1, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 130 | 120.97 | 7.46% | 1 | Jul 1, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 110 130 | 212.77 | -38.9% | 3 | May 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 72 78 | n/a | n/a | 5 | May 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 6 4 | n/a | n/a | 2 | Apr 8, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | n/a | n/a | n/a | 3 | Jan 14, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 60 | n/a | n/a | 1 | Dec 18, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 5 | n/a | n/a | 1 | Dec 18, 2019 |